Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.38 USD | +2.18% | +1.55% | +5.75% |
Apr. 05 | North American Morning Briefing : Investors on -2- | DJ |
Mar. 15 | UBS Adjusts Cryoport Price Target to $17 From $14.50, Maintains Neutral Rating | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an enterprise value anticipated at 3.62 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Air Freight & Logistics
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.75% | 805M | C | ||
-12.27% | 6.63B | - | ||
+30.45% | 5.63B | - | ||
+17.57% | 4.04B | D | ||
+11.93% | 2.26B | B- | ||
+5.06% | 995M | - | - | |
+93.91% | 931M | B | ||
-18.56% | 555M | - | - | |
+1.93% | 504M | - | - | |
-30.92% | 496M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CYRX Stock
- Ratings Cryoport, Inc.